FACTORS ASSOCIATED WITH INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Hammou, O. [1 ]
Chennouf, F. [1 ]
Azzouzi, H. [1 ]
Linda, I. [1 ]
机构
[1] Mohammed I Univ, Mohammed Univ Hosp 6, Dept Rheumatol, Oujda, Morocco
关键词
D O I
10.1136/annrheumdis-2020-eular.5633
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0293
引用
收藏
页码:1441 / 1441
页数:1
相关论文
共 50 条
  • [41] Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions
    Abasolo, Lydia
    Leon, Leticia
    Rodriguez-Rodriguez, Luis
    Tobias, Aurelio
    Rosales, Zulema
    Leal, Jose Maria
    Castano, Victor
    Vadillo, Cristina
    Macarron, Pilar
    Fontsere, Oscar
    Jover, Juan Angel
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (05) : 506 - 513
  • [42] The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Otani, Hiroshi
    Abe, Asami
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    INTERNAL MEDICINE, 2023, 62 (03) : 373 - 379
  • [43] Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily B.
    Muntner, Paul
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (08) : 1004 - 1018
  • [44] Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs
    Ozen, Gulsen
    Pedro, Sofia
    England, Bryant R.
    Mehta, Bella
    Wolfe, Frederick
    Michaud, Kaleb
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 424 - 432
  • [45] Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study
    Freitas, Raquel
    Godinho, Fatima
    Madeira, Nathalie
    Fernandes, Bruno Miguel
    Costa, Flavio
    Santiago, Mariana
    Neto, Agna
    Azevedo, Soraia
    Couto, Maura
    Sequeira, Graca
    Dias, Joao Madruga
    Bernardes, Miguel
    Miranda, Luis
    Pereira, Joaquim Polido
    Fonseca, Joao Eurico
    Santos, Maria Jose
    DRUGS & AGING, 2020, 37 (12) : 899 - 907
  • [46] Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study
    Raquel Freitas
    Fátima Godinho
    Nathalie Madeira
    Bruno Miguel Fernandes
    Flávio Costa
    Mariana Santiago
    Agna Neto
    Soraia Azevedo
    Maura Couto
    Graça Sequeira
    João Madruga Dias
    Miguel Bernardes
    Luís Miranda
    Joaquim Polido Pereira
    João Eurico Fonseca
    Maria José Santos
    Drugs & Aging, 2020, 37 : 899 - 907
  • [47] HOW EFFECTIVE AND SAFE ARE BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN ELDERLY AND VERY ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS?
    Freitas, R.
    Madeira, N.
    Fernandes, B. M.
    Costa, F.
    Santiago, M.
    Neto, A.
    Azevedo, S.
    Madruga Dias, J.
    Couto, M.
    Bernardes, M.
    Cunha Miranda, L.
    Polido-Pereira, J.
    Fonseca, J. E.
    Santos, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 294 - 295
  • [48] Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Cagnotto, Giovanni
    Einarsson, Jon Thorkell
    Turesson, Carl
    BMJ OPEN, 2024, 14 (02):
  • [49] Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
    Jin, Xue-Mei
    Lee, Joongyub
    Choi, Nam-Kyong
    Seong, Jong-Mi
    Shin, Ju-Young
    Kim, Ye-Jee
    Kim, Mi-Sook
    Yang, Bo Ram
    Park, Byung-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (02) : 210 - 216
  • [50] Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
    Xia, Yunfei
    Yin, Rulan
    Fu, Ting
    Zhang, Lijuan
    Zhang, Qiuxiang
    Guo, Genkai
    Li, Liren
    Gu, Zhifeng
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 735 - 742